The non-invasive 13C-methionine breath test detects hepatic mitochondrial dysfunction as a marker of disease activity in non-alcoholic steatohepatitis

European Journal of Medical Research

Volumn 16, Issue 6, 2011, Pages 258-264

  Banasch, Matthias ^a   Ellrichmann, M ^a   Tannapfel, A ^b   Schmidt, W E ^a   Goetze, O ^c  

^a ST JOSEF HOSPITAL   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

MeBT; NASH

Indexed keywords

METHIONINE C 13; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; CARBON METHIONINE C 13;

ADULT; ARTICLE; BREATH ANALYSIS; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE MARKER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER MITOCHONDRION; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; SCORING SYSTEM; AREA UNDER THE CURVE; COHORT ANALYSIS; DIGESTIVE SYSTEM DISEASE ASSESSMENT; DISEASE SEVERITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; LIVER NECROSIS; NASH SCORING SYSTEM; NON INVASIVE PROCEDURE; RECEIVER OPERATING CHARACTERISTIC;

EID: 79960232654     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: 10.1186/2047-783x-16-6-258     Document Type: Article

References (27)

1. McCullough AJ. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clin Liver Dis 2004;8(3):521-33, viii.
2. Clark JM. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol 2006;40(3 Suppl 1):S5-10.
3. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006;43(2 Suppl 1):S99-S112.
4. Begriche K, Igoudjil A, Pessayre D, Fromenty B. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 2006;6(1):1-28.
5. Caldwell SH, Swerdlow RH, Khan EM, Iezzoni JC, Hespenheide EE, Parks JK, et al. Mitochondrial abnormalities in non-alcoholic steatohepatitis. J Hepatol 1999;31(3):430-4.
6. Perez-Carreras M, Del Hoyo P, Martin MA, Rubio JC, Martin A, Castellano G, et al. Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology 2003;38(4):999-1007. (Pubitemid 37221683)
7. Ibdah JA, Perlegas P, Zhao Y, Angdisen J, Borgerink H, Shadoan MK, et al. Mice heterozygous for a defect in mitochondrial trifunctional protein develop hepatic steatosis and insulin resistance. Gastroenterology 2005;128(5):1381-90. (Pubitemid 40712187)
8. Valerio A, Cardile A, Cozzi V, Bracale R, Tedesco L, Pisconti A, et al. TNF-alpha downregulates eNOS expression and mitochondrial biogenesis in fat and muscle of obese rodents. J Clin Invest 2006;116(10):2791-8. (Pubitemid 44511642)
9. Wei Y, Rector RS, Thyfault JP, Ibdah JA. Nonalcoholic fatty liver disease and mitochondrial dysfunction. World J Gastroenterol 2008;14(2):193-9. (Pubitemid 351314298)
10. 13C]Methionine breath test: a novel method to detect antiretroviral drug-related mitochondrial toxicity. J Antimicrob Chemother 2005;55(1):84-9. (Pubitemid 40192618)
11. 13C-methionine breath test. Scand J Gastroenterol 2000;35(6):650-3. (Pubitemid 30441718)
12. 13C- methionine breath test in patients with macrovesicular steatosis and patients with cirrhosis. Med Sci Monk 2003;9(1):CR6-11.
13. 13C-methionine breath test detects distinct hepatic mitochondrial dysfunction in HIV-infected patients with normal serum lactate. J Acquir Immune Defic Syndr 2005;40(2):149-54. (Pubitemid 41395712)
14. Banasch M, Goetze O, Knyhala K, Potthoff A, Schlottmann R, Kwiatek MA, et al. Uridine supplementation enhances hepatic mitochondrial function in thymidine-analogue treated HIV-infected patients. Aids 2006;20(11):1554-6. (Pubitemid 44100218)
15. Banasch M, Emminghaus R, Ellrichmann M, Schmidt WE, Goetze O. Longitudinal effects of hepatitis C virus treatment on hepatic mitochondrial dysfunction assessed by C-methionine breath test. Aliment Pharmacol Ther 2008;28(4):443-9. (Pubitemid 352033277)
16. Banasch M, Goetze O, Schmidt WE, Meier JJ. Rimonabant as a novel therapeutic option for nonalcoholic steatohepatitis. Liver Int 2007;27(8):1152-5. (Pubitemid 47399452)
17. Portincasa P, Grattagliano I, Lauterburg BH, Palmieri VO, Palasciano G, Stellaard F. Liver breath tests non-invasively predict higher stages of non-alcoholic steatohepatitis. Clin Sci (Lond) 2006;111(2):135-43. (Pubitemid 44220527)
18. 13C-Caffeine Breath Test Detects Significant Fibrosis in Patients With Nonalcoholic Steatohepatitis. J Clin Gastroenterol 2008;42(4):408-412.
19. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41(6):1313-21. (Pubitemid 40770284)
20. Yoneda M, Mawatari H, Fujita K, Endo H, Iida H, Nozaki Y, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). Dig Liver Dis 2008;40(5):371-8.
21. Wieckowska A, Zein NN, Yerian LM, Lopez AR, McCullough AJ, Feldstein AE. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in non-alcoholic fatty liver disease. Hepatology 2006;44(1):27-33.
22. Feldstein AE, Wieckowska A, Lopez AR, Liu YC, Zein NN, McCullough AJ. Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study. Hepatology 2009;50(4):1072-8.
23. Diab DL, Yerian L, Schauer P, Kashyap SR, Lopez R, Hazen SL, et al. Cytokeratin 18 fragment levels as a non-invasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients. Clin Gastroenterol Hepatol 2008;6(11):1249-54.
24. Sparks LM, Xie H, Koza RA, Mynatt R, Hulver MW, Bray GA, et al. A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle. Diabetes 2005;54(7):1926-33. (Pubitemid 40911253)
25. Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S, et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A 2003;100(14):8466-71. (Pubitemid 36842568)
26. Banasch M, Knyhala K, Kollar S, Serova K, Potthoff A, Schlottmann R, et al. Disease- and treatment-related predictors of hepatic mitochondrial dysfunction in chronic HIV infection assessed by non-invasive (13)C-methionine breath test diagnostic. Eur J Med Res 2008;13(9):401-8.
27. Banasch M, Frank J, Serova K, Knyhala K, Kollar S, Potthoff A, et al. Impact of antiretroviral treatment on (13)C-methionine metabolism as a marker of hepatic mitochondrial function: a longitudinal study. HIV Med. 2010 May 23. [Epub ahead of print]